GGrantIndex
← Leaderboards

Robert W. Coombs

University Of Washington

$29,428,054
Attributed
$29,428,054
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $7M · FY200517
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17

Funding mix

By agency

NIH$36,972,951 · 7

By mechanism

UM1$26,602,045 · 1
P01$7,544,897 · 2
P30$1,402,906 · 2
R01$999,213 · 1
R21$423,890 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Hiv Infections

Research focus

Hiv InfectionsFemaleSpecimenPreventionHiv-1InfectionClinical ResearchPolymerase Chain ReactionHuman Immunodeficiency Virus 1MolecularResearch PersonnelProceduresInternationalImmunologyMalignant NeoplasmsProgramsSiteLaboratoriesVirologyGenital SecretionViralCommunicable Disease TransmissionMonitorBase

Grant awards (28)

Laboratory Center, AIDS Clinical Trials Group (ACTG); LC 2 / 3$6,624,131
UM1 · FY2017 · AI · contact PI
Laboratory Center, AIDS Clinical Trials Group (ACTG); LC 2 / 3$6,641,277
UM1 · FY2016 · AI · contact PI
Laboratory Center, AIDS Clinical Trials Group (ACTG); LC 2 / 3$6,969,759
UM1 · FY2015 · AI · contact PI
Laboratory Center, AIDS Clinical Trials Group (ACTG); LC 2 / 3$6,366,878
UM1 · FY2014 · AI · contact PI
Clinical Retrovirology$289,776
P30 · FY2012 · AI · contact PI
Clinical Retrovirology$315,854
P30 · FY2011 · AI · contact PI
Clinical Retrovirology$173,654
P30 · FY2010 · AI · contact PI
Clinical Retrovirology$178,797
P30 · FY2009 · AI · contact PI
Clinical Retrovirology$188,846
P30 · FY2008 · AI · contact PI
Initiating Studies of Genitourinary HIV-1 Shedding among Kenyan Men$183,789
R21 · FY2008 · HD · contact PI
Initiating Studies of Genitourinary HIV-1 Shedding among Kenyan Men$240,101
R21 · FY2007 · HD · contact PI
HIV-1 SHEDDING FROM FEMALE GENITAL TRACT$666,666
P01 · FY2006 · HD · contact PI
HIV-1 SHEDDING FROM FEMALE GENITAL TRACT$300,000
P01 · FY2006 · HD · contact PI
HIV-1 SHEDDING FROM FEMALE GENITAL TRACT$1,286,153
P01 · FY2005 · HD
Oral HIV Pathogenesis and Shedding$333,071
R01 · FY2005 · DE
HIV-1 SHEDDING FROM FEMALE GENITAL TRACT$1,248,693
P01 · FY2004 · HD
Oral HIV Pathogenesis and Shedding$333,071
R01 · FY2004 · DE
Core Clinical Retrovirology$77,531
P30 · FY2004 · AI
HIV-1 SHEDDING FROM FEMALE GENITAL TRACT$1,511,632
P01 · FY2003 · HD
Oral HIV Pathogenesis and Shedding$333,071
R01 · FY2003 · DE
HIV-1 SHEDDING FROM FEMALE GENITAL TRACT$1,177,191
P01 · FY2002 · HD
HIV-1 SHEDDING FROM FEMALE GENITAL TRACT$166,307
P01 · FY2002 · HD
CORE--CLINICAL RETROVIROLOGY$0
P30 · FY2002 · AI
CORE--LABORATORY$0
P01 · FY2002 · HD
CORE--LABORATORY$0
P01 · FY2002 · HD
HIV-1 SHEDDING FROM FEMALE GENITAL TRACT$1,188,255
P01 · FY2001 · HD
CORE--CLINICAL RETROVIROLOGY$0
P30 · FY2001 · AI
CORE--CLINICAL RETROVIROLOGY$178,448
P30 · FY2000 · AI